Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep 3;21(17):6447.
doi: 10.3390/ijms21176447.

LncRNAs in the Type I Interferon Antiviral Response

Affiliations
Review

LncRNAs in the Type I Interferon Antiviral Response

Beatriz Suarez et al. Int J Mol Sci. .

Abstract

The proper functioning of the immune system requires a robust control over a delicate equilibrium between an ineffective response and immune overactivation. Poor responses to viral insults may lead to chronic or overwhelming infection, whereas unrestrained activation can cause autoimmune diseases and cancer. Control over the magnitude and duration of the antiviral immune response is exerted by a finely tuned positive or negative regulation at the DNA, RNA, and protein level of members of the type I interferon (IFN) signaling pathways and on the expression and activity of antiviral and proinflammatory factors. As summarized in this review, committed research during the last decade has shown that several of these processes are exquisitely regulated by long non-coding RNAs (lncRNAs), transcripts with poor coding capacity, but highly versatile functions. After infection, viruses, and the antiviral response they trigger, deregulate the expression of a subset of specific lncRNAs that function to promote or repress viral replication by inactivating or potentiating the antiviral response, respectively. These IFN-related lncRNAs are also highly tissue- and cell-type-specific, rendering them as promising biomarkers or therapeutic candidates to modulate specific stages of the antiviral immune response with fewer adverse effects.

Keywords: LncRNAs; antiviral response; type I IFN.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Long non-coding RNA (LncRNA) classification according to their genomic context relative to protein-coding genes (PCGs) and their regulatory DNA elements. See text for details.
Figure 2
Figure 2
LncRNAs affect protein activity directly or by regulating transcriptional and post-transcriptional processes in the nucleus (on the left) or in the cytoplasm (on the right). These effects result from the ability of lncRNAs to form primary, secondary, and tertiary structures able to bind DNA, RNA, or proteins. See text for details. Blue arrows depict activation while the red arrows, inhibition.
Figure 3
Figure 3
LncRNAs affect many steps of the interferon (IFN) synthesis (left) and signaling pathways (right). See text for details. LncRNA-linked blue arrows depict activation while red arrows indicate inhibition. Name frames are in blue for activating lncRNAs, red for inhibitory lncRNAs, and in both colors for lncRNAs with dual functions.

References

    1. Iyer M.K., Niknafs Y.S., Malik R., Singhal U., Sahu A., Hosono Y., Barrette T.R., Prensner J.R., Evans J.R., Zhao S., et al. The landscape of long noncoding RNAs in the human transcriptome. Nat. Genet. 2015;47:199–208. doi: 10.1038/ng.3192. - DOI - PMC - PubMed
    1. Ransohoff J.D., Wei Y., Khavari P.A. The functions and unique features of long intergenic non-coding RNA. Nat. Rev. Mol. Cell Biol. 2018;19:143–157. doi: 10.1038/nrm.2017.104. - DOI - PMC - PubMed
    1. Cabili M.N., Trapnell C., Goff L., Koziol M., Tazon-Vega B., Regev A., Rinn J.L. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 2011;25:1915–1927. doi: 10.1101/gad.17446611. - DOI - PMC - PubMed
    1. Djebali S., Davis C.A., Merkel A., Dobin A., Lassmann T., Mortazavi A., Tanzer A., Lagarde J., Lin W., Schlesinger F., et al. Landscape of transcription in human cells. Nature. 2012;489:101–108. doi: 10.1038/nature11233. - DOI - PMC - PubMed
    1. Unfried J.P., Serrano G., Suárez B., Sangro P., Ferretti V., Prior C., Boix L., Bruix J., Sangro B., Segura V., et al. Identification of Coding and Long Noncoding RNAs Differentially Expressed in Tumors and Preferentially Expressed in Healthy Tissues. Cancer Res. 2019;79:5167–5180. doi: 10.1158/0008-5472.CAN-19-0400. - DOI - PubMed